| Company/Division name | Thermo Fisher Scientific |
| Type of work | Manufacturing |
| If manufacturing, is the company a contract manufacturer? | Yes |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 1400 |
| Year reshoring announced: | 2021 |
| Year reshoring implemented or to be implemented: | 2022 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 100 |
| City reshored to: | Nashville |
| State(s) reshored to: | TN |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | Single-use technology (SUT) products |
| What domestic positive factors made reshoring more attractive? | Lead time/Time to market, Lean/other business process improvement techniques, Other, import replacement, Covid-19 |
